| 中文名 | Balamapimod |
|---|---|
| 英文名 | 4-[3-chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile |
| 中文别名 | 4-[[3-氯-4-[(1-甲基-1H-咪唑-2-基)硫基]苯基]氨基]-6-甲氧基-7-[4-(1-吡咯烷基)-1-哌啶基]-3-喹啉腈 |
| 英文别名 |
Balamapimod (USAN)
3-Quinolinecbonitrile, 4-[[3-chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl]amino]-6-methoxy-7-[4-(1-pyrrolidinyl)-1-piperidinyl] Balamapimod MKI-833 4-({3-chloro-4-[(1-methyl-1H-imidazole-2-yl)thio]phenyl}amino)-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile UNII-7Y0IV7N95Q BalaMapiMod (MKI-833) 4-({3-chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl}amino)-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile |
| 描述 | MKI 833 (Balamapimod) 是一个具有潜在抗肿瘤活性的、Ras/Raf/MEK 的可逆 抑制剂。 |
|---|---|
| 相关类别 | |
| 靶点 |
MEK |
| 参考文献 |
| 分子式 | C30H32ClN7OS |
|---|---|
| 分子量 | 574.13900 |
| 精确质量 | 573.20800 |
| PSA | 110.77000 |
| LogP | 5.88618 |
|
~%
863029-99-6 |
| 文献:Wyeth Patent: US2005/187247 A1, 2005 ; Location in patent: Page/Page column 23 ; US 20050187247 A1 |